Ignite Creation Date:
2025-12-25 @ 1:26 AM
Ignite Modification Date:
2025-12-27 @ 11:16 PM
Study NCT ID:
NCT00390793
Status:
COMPLETED
Last Update Posted:
2025-02-17
First Post:
2006-10-18
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Combination Chemotherapy and Dasatinib in Treating Participants With Philadelphia Positive or BCR-ABL Positive Acute Lymphoblastic Leukemia.
Sponsor:
M.D. Anderson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-09-28
Start Date Type:
ACTUAL
Primary Completion Date:
2024-02-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-02-02
Completion Date Type:
ACTUAL
First Submit Date:
2006-10-18
First Submit QC Date:
None
Study First Post Date:
2006-10-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2025-01-30
Results First Submit QC Date:
None
Results First Post Date:
2025-02-17
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-01-30
Last Update Post Date:
2025-02-17
Last Update Post Date Type:
ACTUAL